piribedil has been researched along with Raynaud Disease in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allegra, C | 1 |
| Pollari, G | 1 |
1 other study available for piribedil and Raynaud Disease
| Article | Year |
|---|---|
Aimed pharmacological treatment of Raynaud's disease.
Topics: Adult; Benzyl Compounds; Dihydroergotoxine; Ethanolamines; Female; Hand; Humans; Middle Aged; Nitrog | 1979 |